logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12098384 B1

PDFFull Text
Date of Patent:
Sep. 24, 2024

Filed:

Jan. 20, 2022

Adenoviral vector not including replication competent adenovirus, and use thereof

Applicant:

Cellid Co., Ltd., Seoul, KR;

Inventors:

Chang-Yuil Kang, Seoul, KR;

Bongju Park, Seoul, KR;

Kwang-Soo Shin, Seoul, KR;

Tae-Gwon Oh, Seoul, KR;

Assignee:

Cellid Co., Ltd., Seoul, KR;

Attorney:

Klarquist Sparkman, LLP

Primary Examiner:

Janet L Andres

Assistant Examiner:

Ruixue Wang

Int. Cl.
CPC ...
C12N 15/86 (2006.01); C07K 14/165 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/165 (2013.01); A61K 2039/5256 (2013.01); C12N 2710/10022 (2013.01); C12N 2710/10041 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01);
Abstract

The present invention relates to a novel adenoviral vector not including a replication competent adenovirus. A recombinant E1/E3/E4-deleted adenoviral vector, of the present invention, in which an antigenic protein and an E4orf6 gene are inserted in an E1 gene-deleted region, has adenovirus productivity, degree of antigen expression, neutralizing antibody production amount, and T cell induction ability that are similar to those of a control group, and thus can be effectively used as a carrier for various vaccines for diseases or anti-cancer vaccines.

Find Patent Forward Citations

Kang, Chang-Yuil. (2024). Adenoviral vector not including replication competent adenovirus, and use thereof (U.S. Patent No. 12098384). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12098384

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…